56 related articles for article (PubMed ID: 30179634)
21. Screening and characterization of inhibitory vNAR targeting nanodisc-assembled influenza M2 proteins.
Yu C; Ding W; Zhu L; Zhou Y; Dong Y; Li L; Liu J; Wang Y; Li Z; Zhu L; Chen F; Ruan M; Qian D; Wang Y; Wu B; Xu H; Li M; Bi Y; Wang H; Wang W; Chao P; Xing L; Shen B; Dai H; Zha L; Zhao H; Wang J
iScience; 2023 Jan; 26(1):105736. PubMed ID: 36570769
[TBL] [Abstract][Full Text] [Related]
22. Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle.
Kim KH; Li Z; Bhatnagar N; Subbiah J; Park BR; Shin CH; Pushko P; Wang BZ; Kang SM
PLoS Pathog; 2022 Aug; 18(8):e1010755. PubMed ID: 36006890
[TBL] [Abstract][Full Text] [Related]
23. Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies.
Oltean T; Ibanez LI; Divert T; Ysenbaert T; Van Eeckhoutte H; Goossens V; Schotsaert M; Bracke K; Schepens B; Maelfait J; Takahashi N; Saelens X; Vandenabeele P
Cell Death Dis; 2022 Mar; 13(3):280. PubMed ID: 35351865
[TBL] [Abstract][Full Text] [Related]
24. Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections.
Keeler SP; Fox JM
Viruses; 2021 May; 13(6):. PubMed ID: 34072720
[TBL] [Abstract][Full Text] [Related]
25. Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A.
Bimler L; Ronzulli SL; Song AY; Johnson SK; Jones CA; Kim T; Le DT; Tompkins SM; Paust S
J Virol; 2021 Mar; 95(5):. PubMed ID: 33268521
[TBL] [Abstract][Full Text] [Related]
26. Engineered Recombinant Single Chain Variable Fragment of Monoclonal Antibody Provides Protection to Chickens Infected with H9N2 Avian Influenza.
Lukosaityte D; Sadeyen JR; Shrestha A; Sealy JE; Bhat S; Chang P; Digard P; Iqbal M
Vaccines (Basel); 2020 Mar; 8(1):. PubMed ID: 32138253
[TBL] [Abstract][Full Text] [Related]
27. Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection.
De Vlieger D; Hoffmann K; Van Molle I; Nerinckx W; Van Hoecke L; Ballegeer M; Creytens S; Remaut H; Hengel H; Schepens B; Saelens X
Front Immunol; 2019; 10():2920. PubMed ID: 31921179
[TBL] [Abstract][Full Text] [Related]
28. M2e-based universal influenza vaccines: a historical overview and new approaches to development.
Mezhenskaya D; Isakova-Sivak I; Rudenko L
J Biomed Sci; 2019 Oct; 26(1):76. PubMed ID: 31629405
[TBL] [Abstract][Full Text] [Related]
29. Super-resolution microscopy reveals significant impact of M2e-specific monoclonal antibodies on influenza A virus filament formation at the host cell surface.
Kolpe A; Arista-Romero M; Schepens B; Pujals S; Saelens X; Albertazzi L
Sci Rep; 2019 Mar; 9(1):4450. PubMed ID: 30872764
[TBL] [Abstract][Full Text] [Related]
30. Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles.
Lee YT; Kim KH; Ko EJ; Kim MC; Lee YN; Hwang HS; Lee Y; Jung YJ; Kim YJ; Santos J; Perez DR; Kang SM
Virology; 2019 Mar; 529():111-121. PubMed ID: 30685658
[TBL] [Abstract][Full Text] [Related]
31. Vaccine options for influenza: thinking small.
Schepens B; De Vlieger D; Saelens X
Curr Opin Immunol; 2018 Aug; 53():22-29. PubMed ID: 29631195
[TBL] [Abstract][Full Text] [Related]
32. Influenza A viruses: why focusing on M2e-based universal vaccines.
Ebrahimi SM; Tebianian M
Virus Genes; 2011 Feb; 42(1):1-8. PubMed ID: 21082230
[TBL] [Abstract][Full Text] [Related]
33. Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice.
Kolpe A; Schepens B; Ye L; Staeheli P; Saelens X
Antiviral Res; 2018 Oct; 158():244-254. PubMed ID: 30179634
[TBL] [Abstract][Full Text] [Related]
34. Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies.
Van den Hoecke S; Ehrhardt K; Kolpe A; El Bakkouri K; Deng L; Grootaert H; Schoonooghe S; Smet A; Bentahir M; Roose K; Schotsaert M; Schepens B; Callewaert N; Nimmerjahn F; Staeheli P; Hengel H; Saelens X
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077656
[TBL] [Abstract][Full Text] [Related]
35. Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.
El Bakkouri K; Descamps F; De Filette M; Smet A; Festjens E; Birkett A; Van Rooijen N; Verbeek S; Fiers W; Saelens X
J Immunol; 2011 Jan; 186(2):1022-31. PubMed ID: 21169548
[TBL] [Abstract][Full Text] [Related]
36. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.
Stepanova LA; Kotlyarov RY; Kovaleva AA; Potapchuk MV; Korotkov AV; Sergeeva MV; Kasianenko MA; Kuprianov VV; Ravin NV; Tsybalova LM; Skryabin KG; Kiselev OI
PLoS One; 2015; 10(3):e0119520. PubMed ID: 25799221
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
